Predicting survival in ambulatory patients with severe heart failure on beta-blocker therapy.
暂无分享,去创建一个
[1] G. Ewald,et al. The effect of β-adrenergic blockers on the prognostic value of peak exercise oxygen uptake in patients with heart failure , 2003 .
[2] G. MacGowan,et al. Impact of beta-blocker therapy on functional capacity criteria for heart transplant listing. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[3] W. Kübler,et al. Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure. , 2002, Journal of the American College of Cardiology.
[4] R. Berger,et al. Long-term effect of atenolol on ejection fraction, symptoms, and exercise variables in patients with advanced left ventricular dysfunction. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[5] W. Kübler,et al. Risk stratification in middle‐aged patients with congestive heart failure: prospective comparison of the Heart Failure Survival Score (HFSS) and a simplified two‐variable model , 2001, European journal of heart failure.
[6] H. Scheld,et al. Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity , 2000, BMJ : British Medical Journal.
[7] J. Myers,et al. Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited. , 2000, American heart journal.
[8] Fach,et al. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.
[9] J. Schwartz,et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. , 1996, Circulation.
[10] J. Cohn,et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.
[11] J. Medbø,et al. The effect of acute vs chronic treatment with beta-adrenoceptor blockade on exercise performance, haemodynamic and metabolic parameters in healthy men and women. , 1996, British journal of clinical pharmacology.
[12] D. Mancini,et al. Is percentage of predicted maximal exercise oxygen consumption a better predictor of survival than peak exercise oxygen consumption for patients with severe heart failure? , 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[13] J R Wilson,et al. Value of Peak Exercise Oxygen Consumption for Optimal Timing of Cardiac Transplantation in Ambulatory Patients With Heart Failure , 1991, Circulation.